{
  "id": 19327622,
  "title": "Pfizer Hits a New 52-Week High. Here's Why It's Not Too Late to Buy the Stock",
  "url": "https://urgent.news/2026/11/10/pfizer-hits-a-new-52-week-high-heres-why-its-not-too-late-to-buy-the-19327622",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-10T11:20:02.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/pfizer-hits-new-52-week-high-heres-why-its-not-too-late-buy-stock"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsPfizer's recently launched and acquired products have been generating impressive growth.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}